Go Pro
NASDAQ:ASPI

ASP Isotopes Q1 2026 Earnings Report

ASP Isotopes logo
$6.17 -0.05 (-0.80%)
Closing price 04:00 PM Eastern
Extended Trading
$6.21 +0.04 (+0.65%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ASP Isotopes EPS Results

Actual EPS
-$0.22
Consensus EPS
-$0.28
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

ASP Isotopes Revenue Results

Actual Revenue
$8.36 million
Expected Revenue
$3.68 million
Beat/Miss
Beat by +$4.68 million
YoY Revenue Growth
N/A

ASP Isotopes Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Wednesday, May 20, 2026
Conference Call Time
7:00AM ET

Upcoming Earnings

ASP Isotopes' Q2 2026 earnings is estimated for Friday, August 14, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

ASP Isotopes Earnings Headlines

ASPI Share News Today
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI), a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

View ASP Isotopes Profile